Psoriasis
CHRONIC PLAQUE PSORIASIS RESEARCH TRIAL (24 WEEKS)
Adults aged 18 years or older with a clinical diagnosis of plaque psoriasis of at least 6 months duration, may qualify for this research trial and receive investigational topical treatment (active study drug) or placebo.
Individuals must have the disease affecting 3%-15% of the body surface area (BSA) (excluding head) to be eligible for topical treatment. Adults must not have other types of psoriasis dominant other than plaque psoriasis. During the study period, participants must also agree not to have prolonged sun exposure. Eligible participants will have regular visits with our experienced research team.
There is no cost to participate, and participants will be reimbursed for study-related expenses.
Individuals will be asked to visit the study centre about 8 times over a period of about 24 weeks.
For more information, please contact:
Principal Investigator
A/Prof Peter Foley
Sub Investigators
Dr Nisal Punchihewa
t: 9623 9464
e:Â [email protected]
Study Coordinator
Natasha Harrison
t: 9623 9435
e:Â [email protected]
PLAQUE PSORIASIS CLINICAL TRIAL (32 WEEKS)
Adults aged 18 years or older who have a diagnosis of plaque psoriasis for 6 months or longer, may qualify for this clinical research trial and receive either an investigational oral medication (active study drug), placebo, or an approved comparator medication.
Eligible participants must have plaques covering 10% or more of their body surface area (BSA), with moderate to severe disease, deemed by the study doctor to be a candidate for phototherapy or systemic therapy. Participants will have regular visits with an experienced research team. There is
no cost to participate, and participants will be reimbursed for study-related expenses.
Individuals will be asked to visit the study centre about 11 times over a period of about 32 weeks.
For more information, please contact:
Principal Investigator
A/Prof Peter Foley
Sub Investigators
Dr Nisal Punchihewa
t: 9623 9464
e:Â [email protected]
Study Coordinator
Asami Weaver
t: 9623 9439
e:Â [email protected]
